Vishwanath, Sneha http://orcid.org/0000-0001-9960-547X
Carnell, George William http://orcid.org/0000-0001-8875-0989
Ferrari, Matteo
Asbach, Benedikt http://orcid.org/0000-0003-1056-8591
Billmeier, Martina
George, Charlotte http://orcid.org/0000-0002-6585-3288
Sans, Maria Suau
Nadesalingam, Angalee
Huang, Chloe Qingzhou http://orcid.org/0009-0009-1503-1030
Paloniemi, Minna http://orcid.org/0000-0001-9288-4461
Stewart, Hazel http://orcid.org/0000-0003-1438-1089
Chan, Andrew
Wells, David Arthur http://orcid.org/0000-0002-4531-5968
Neckermann, Patrick
Peterhoff, David
Einhauser, Sebastian
Cantoni, Diego
Neto, Martin Mayora http://orcid.org/0000-0002-5331-5554
Jordan, Ingo http://orcid.org/0000-0003-2711-7252
Sandig, Volker
Tonks, Paul
Temperton, Nigel http://orcid.org/0000-0002-7978-3815
Frost, Simon
Sohr, Katharina
Ballesteros, Maria Teresa Lluesma
Arbabi, Farzad
Geiger, Johannes
Dohmen, Christian
Plank, Christian
Kinsley, Rebecca
Wagner, Ralf
Heeney, Jonathan Luke http://orcid.org/0000-0003-2702-1621
Article History
Received: 5 November 2021
Accepted: 23 August 2023
First Online: 25 September 2023
Competing interests
: M.F., D.A.W., S.F., R.K., R.W. and J.L.H. are employees or shareholders of DIOSynVax Ltd. S.F. is an employee of Microsoft. I.J. and V.S. are employees of ProBioGenAG. K.S., M.T.L.B., F.A., J.G., C.D. and C.P. are employees of Ethris GmbH. The sequences of the antigens have been patented under UK Patent Application No. 2303150.3, Coronavirus Vaccines. All other authors have no competing interests.